-
not specified
RNA-seq; Bioinformatics Analysis; Survival Analysis
Within the ELN2022 Favorable subgroup, high expression is associated with worse survival and lower remission rates.
hsa_circ_0080850 (PTPN12-derived) is a subgroup-specific prognostic marker in ELN2022 Favorable AML: high expression predicts poorer survival and markedly lower complete remission rates after induction therapy, with no corresponding prognostic signal from the host gene.
0.348
Landscape of circular RNAs in acute myeloid leukemia and their clinical significance.
combined biological and clinical study